Intrahepatic Cholestasis of Pregnancy
Gastroenterology
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Mirum PharmaceuticalsFOSTER CITY, CA
2 programs2
MaralixibatPhase 21 trial
VolixibatPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Mirum PharmaceuticalsMaralixibat
Mirum PharmaceuticalsVolixibat
Clinical Trials (2)
Total enrollment: 4 patients across 2 trials
Maralixibat for Intrahepatic Cholestasis of Pregnancy
Start: Apr 2026Est. completion: Mar 2028
Phase 2Not Yet Recruiting
A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)
Start: Jan 2021Est. completion: Dec 20224 patients
Phase 2Terminated
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
15h ago
Head of Drug Product Development
Ironwood Pharmaceuticals
Boston, Massachusetts, United States
16h ago
$246K - $287K/yr
Regulatory Affairs Associate
Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday
Key Account Director, Diagnostics and Research
Tempus
Remote
Yesterday
$150K - $200K/yr
Senior Sterilization Validation Engineer (m/f/d)
Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday
Senior Financial Analyst - Supply Chain Finance & Transformation (m/f/d)
Johnson & Johnson
Norderstedt, Schleswig-Holstein, Germany
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space